E7070
Phase 2Completed 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Breast Neoplasms
Conditions
Breast Neoplasms, Metastases
Trial Timeline
Feb 1, 2004 → May 1, 2005
NCT ID
NCT00080197About E7070
E7070 is a phase 2 stage product being developed by Eisai for Breast Neoplasms. The current trial status is completed. This product is registered under clinical trial identifier NCT00080197. Target conditions include Breast Neoplasms, Metastases.
What happened to similar drugs?
20 of 20 similar drugs in Breast Neoplasms were approved
Approved (20) Terminated (4) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00165867 | Phase 2 | Completed |
| NCT00165594 | Phase 1/2 | Terminated |
| NCT00165880 | Phase 2 | Terminated |
| NCT00080197 | Phase 2 | Completed |
| NCT00165854 | Phase 2 | Completed |
| NCT00059735 | Phase 2 | Completed |
Competing Products
20 competing products in Breast Neoplasms